Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Pharmaceutical and surgical therapies for PD are available and can alleviate the symptoms and complications. Unfortunately, despite these therapies, the disease relentlessly progresses. A new study in the journal Value in Health presents a detailed overview of the current decision-analytic models used to evaluate the cost-effectiveness of therapeutic options in Parkinson's disease.

Lead author Uwe Siebert notes "this article gives an insight into the different methodological approaches used to estimate the cost-effectiveness of treatments for a chronic progressive disorder. Cost-effectiveness is an important issue in PD as newer therapeutic options are costly." Corresponding author Richard Dodel stresses, "Although each of these studies has its distinct value, most currently available models do not explicitly capture the large spectrum of clinically relevant symptoms that physicians must consider in daily clinical decision making."

This study aims to provide decision analysts and clinicians interested in formal medical decision making with an insight into the structural and methodological approaches used in PD decision modeling, including their strengths and limitations. Studying the long-term effect of treatment on clinical symptoms and health-related quality of life is important in evaluating PD interventions. However, since most clinical trials are short, mathematical models must be used to link the short-term clinical outcomes from clinical trials with evidence for the long-term progression of the disease. PD is particularly complex because of the wide spectrum of PD symptoms and treatment complications, and the lifelong progression of the disease. The authors conclude that decision-analytic modeling is a useful tool in clinical decision-making and the economic evaluation of interventions in PD. It cannot replace clinical studies but rather complements the
'"/>

Contact: Sharon Agsalda
medicalnews@bos.blackwellpublishing.com
781-388-8507
Blackwell Publishing Ltd.
10-Nov-2004

Page: 1 2
Related medicine news :

1. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
2. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer
3. Older doctors less likely to follow current standards of care
4. Women successfully treated to prevent preterm labor at low risk for recurrent episode
5. New theory chalenges current view of how brain stores long-term memory
6. CDC: Update on current influenza season and vaccine supply in the United States
7. Radiation therapy effective for some patients with recurrent cancer after radical prostatectomy
8. Blood pressure may predict recurrent cardiovascular events in women
9. Experimental drug used to treat recurrent ovarian cancer shows promising results
10. Taking vitamins to lower amino acid level in blood does not reduce the risk of recurrent stroke
11. C-myc causes hormones to lose control in recurrent prostate cancer